Traders should anticipate higher per-share price volatility post-split due to lower float. Monitor trading volume on April 13 for signs of illiquidity. No fundamental change in company value.
Price Chart
Executive Summary
Quince Therapeutics executed a 1-for-10 reverse stock split effective April 10, 2026, reducing its outstanding shares to approximately 16.3 million. The stock will begin trading on a split-adjusted basis on April 13, 2026, under the same ticker QNCX but with a new CUSIP.
Key Facts
- 1-for-10 reverse stock split approved by shareholders and implemented by board
- Effective date: April 10, 2026 at 11:59 PM ET
- Split-adjusted trading begins April 13, 2026 on Nasdaq
- Approximately 16,300,795 shares outstanding post-split
- New CUSIP: 22053A206; ticker unchanged (QNCX)
- All stock options and warrants proportionally adjusted
Financial Impact
No change to market cap; share count reduced by 90%. Post-split shares outstanding: ~16.3 million
Risk Factors
- Potential negative market perception associated with reverse splits (often seen as a sign of distress)
- Reduced liquidity due to lower share count could increase volatility
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-149021 |
| Document: d115661dex31.htm | 0001193125-26-149021 |
| Document: 0001193125-26-149021-index-headers.html | 0001193125-26-149021 |
| Document: 0001193125-26-149021-index.html | 0001193125-26-149021 |
| Document: 0001193125-26-149021.txt | 0001193125-26-149021 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $31.32 $28.59 | ▲ +8.72% | ▲ +7.51% | $30.67 (+2.08%) |
Aug 25, 2026 5w ago | EFFECT | $30.93 $32.11 | ▼ −3.82% | ▼ −4.35% | $30.67 (+0.84%) |
Aug 14, 2026 7w ago | 8-K | $31.34 awaiting T+5 | awaiting T+5 | — | $30.67 (−2.14%) |
Aug 14, 2026 7w ago | Press Release | $31.34 awaiting T+5 | awaiting T+5 | — | $30.67 (−2.14%) |
Aug 5, 2026 8w ago | S-3/A | $28.88 $31.26 | ▲ +8.24% | ▲ +7.89% | $30.67 (+6.20%) |
Jun 11, 2026 16w ago | 3 | $0.9337 $0.9451 | ▲ +1.22% | ▲ +0.55% | $30.67 (+3184.78%) |
May 18, 2026 19w ago | 8-K | $19.90 $24.00 | ▲ +20.60% | ▲ +18.99% | $30.67 (+54.12%) |
Apr 27, 2026 22w ago | DEFA14A | $24.60 $24.60 | · 0.00% | ▼ −1.70% | $30.67 (+24.67%) |
Apr 9, 2026 25w ago | 8-K | $1.24 $1.34 | ▲ +8.06% | ▲ +4.88% | $30.67 (+2373.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access